@article{c777ba1a84a34ae3a742f94782d63663,
title = "Exploring the Food and Drug Administration{\textquoteright}s review and approval of Entresto (sacubitril/valsartan)",
keywords = "NT-proBNP, PARADIGM-HF, PARAGON-HF, pediatric heart failure, postmarketing requirements, sex differences",
author = "Eadie, {Ashley L.} and Brunt, {Keith R.} and Matthew Herder",
note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.",
year = "2021",
month = jun,
doi = "10.1002/prp2.794",
language = "English",
volume = "9",
journal = "Pharmacology Research and Perspectives",
issn = "2052-1707",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "3",
}